[Form 4] Health In Tech, Inc. Insider Trading Activity
Health In Tech, Inc. (HIT) reporting person LinLin Qian, who serves as Chief Financial Officer, Director and a reported 10% owner, received a grant of 27,000 restricted shares of Class A Common Stock on 08/15/2025. The restricted shares were issued under the Health in Tech Equity Incentive Plan and vest based on operational milestones: 50% vest monthly over 12 months after the first specified program is launched and operational, and the remaining 50% vest monthly over 12 months after the second specified program is launched and operational. Following the transaction the reporting person beneficially owns 8,048,555 shares (which the filing states include 55,193 restricted shares and 7,993,362 Class A shares), while the filing excludes certain Class B shares and options.
Health In Tech, Inc. (HIT) - la persona segnalante, LinLin Qian, che ricopre i ruoli di Chief Financial Officer, amministratore e risulta proprietaria del 10% circa, ha ricevuto una concessione di 27.000 azioni vincolate di Classe A Common Stock in data 15/08/2025. Le azioni sono state emesse ai sensi del Health in Tech Equity Incentive Plan e maturano al raggiungimento di milestone operative: il 50% matura mensilmente in 12 mesi a partire dall’avvio operativo del primo programma specificato, e il restante 50% matura mensilmente in 12 mesi dopo l’avvio operativo del secondo programma specificato. A seguito della transazione la persona segnalante detiene beneficiariamente 8.048.555 azioni (la comunicazione indica che queste comprendono 55.193 azioni vincolate e 7.993.362 azioni di Classe A), mentre la segnalazione esclude alcune azioni di Classe B e opzioni.
Health In Tech, Inc. (HIT) - la persona informante, LinLin Qian, quien se desempeña como Directora Financiera, miembro del consejo y propietaria informada del 10%, recibió una concesión de 27.000 acciones restringidas de Clase A Common Stock el 15/08/2025. Las acciones restringidas se emitieron bajo el Health in Tech Equity Incentive Plan y se liberan al cumplirse hitos operativos: el 50% se adquiere mensualmente durante 12 meses tras el lanzamiento y operación del primer programa especificado, y el 50% restante se adquiere mensualmente durante 12 meses tras el lanzamiento y operación del segundo programa especificado. Tras la transacción, la persona informante posee de forma beneficiaria 8.048.555 acciones (el formulario indica que esto incluye 55.193 acciones restringidas y 7.993.362 acciones de Clase A), mientras que se excluyen ciertas acciones de Clase B y opciones.
Health In Tech, Inc. (HIT)의 신고자 LinLin Qian은 최고재무책임자(CFO), 이사이며 보고상 약 10%의 지분을 보유한 자로서 2025년 8월 15일에 27,000주의 Class A 제한주를 부여받았습니다. 해당 제한주는 Health in Tech Equity Incentive Plan에 따라 발행되었으며 운영적 마일스톤에 따라 권리가 취득됩니다: 지정된 첫 번째 프로그램이 가동되어 운영된 이후 12개월 동안 매월 50%가 취득되며, 두 번째 지정 프로그램이 가동되어 운영된 이후 남은 50%가 12개월 동안 매월 취득됩니다. 거래 이후 신고자는 8,048,555주를 실질적으로 보유하게 되며(보고서에 따르면 이에는 55,193주의 제한주와 7,993,362주의 Class A 주식이 포함됩니다), 일부 Class B 주식과 옵션은 보고서에서 제외되어 있습니다.
Health In Tech, Inc. (HIT) - la personne déclarante, LinLin Qian, qui occupe les postes de Chief Financial Officer, administratrice et détient environ 10% signalés, a reçu une attribution de 27 000 actions restreintes de Class A Common Stock le 15/08/2025. Les actions restreintes ont été émises dans le cadre du Health in Tech Equity Incentive Plan et sont soumises à des jalons opérationnels : 50% acquièrent droit mensuellement sur 12 mois après le lancement et la mise en service du premier programme spécifié, et les 50% restants acquièrent droit mensuellement sur 12 mois après le lancement et la mise en service du second programme spécifié. À la suite de la transaction, la personne déclarante détient de manière bénéficiaire 8 048 555 actions (la déclaration indique que cela inclut 55 193 actions restreintes et 7 993 362 actions de Classe A), certaines actions de Classe B et options étant exclues de la déclaration.
Health In Tech, Inc. (HIT) - die meldende Person LinLin Qian, die als Chief Financial Officer, Direktorin und mit rund 10% gemeldete Anteilseignerin fungiert, erhielt am 15.08.2025 eine Zuteilung von 27.000 eingeschränkten Aktien der Klasse A Common Stock. Die Restricted Shares wurden im Rahmen des Health in Tech Equity Incentive Plan ausgegeben und werden nach operativen Meilensteinen freigegeben: 50% werden monatlich über 12 Monate nach Inbetriebnahme des ersten genannten Programms zugeteilt, die verbleibenden 50% monatlich über 12 Monate nach Inbetriebnahme des zweiten genannten Programms. Nach der Transaktion besitzt die meldende Person wirtschaftlich 8.048.555 Aktien (laut Einreichung davon 55.193 Restricted Shares und 7.993.362 Class A-Aktien), während bestimmte Class B-Aktien und Optionen in der Einreichung ausgeschlossen sind.
- 27,000 restricted Class A shares granted to the CFO/Director, aligning pay with company operational milestones
- Vesting is milestone-based (two product launches), which ties value realization to execution rather than time-only vesting
- Reporting person retains significant ownership with 8,048,555 beneficially owned shares, indicating management stake
- None.
Insights
TL;DR: Insider CFO received milestone-based restricted stock, aligning executive incentives with product launches while modestly increasing reported ownership.
The grant of 27,000 restricted Class A shares ties management compensation to the operational launch of two specified programs, which strengthens alignment between executive incentives and company milestones. Vesting is milestone-linked rather than time-only, which may reduce gratuitous near-term dilution and focuses value delivery on execution. The reporting person remains a substantial holder with 8,048,555 beneficially owned shares, improving perceived management skin in the game. The filing excludes Class B shares and outstanding options, so total economic exposure is larger than Class A counts alone.
TL;DR: The transaction is a routine, non-cash equity grant that is execution-contingent and unlikely to materially affect near-term cap structure.
The 27,000-share award at $0 price indicates restricted shares issued as compensation rather than market purchases. Because vesting depends on successful launches, immediate dilution is limited to recorded outstanding shares; the filing shows 55,193 restricted shares included in beneficial ownership. Investors should note that additional instruments (2,700,000 Class B shares and 711,510 options) are excluded from the Class A total in this report, so full potential dilution requires reviewing other filings. Overall, this Form 4 documents governance-aligned compensation rather than capital-market activity.
Health In Tech, Inc. (HIT) - la persona segnalante, LinLin Qian, che ricopre i ruoli di Chief Financial Officer, amministratore e risulta proprietaria del 10% circa, ha ricevuto una concessione di 27.000 azioni vincolate di Classe A Common Stock in data 15/08/2025. Le azioni sono state emesse ai sensi del Health in Tech Equity Incentive Plan e maturano al raggiungimento di milestone operative: il 50% matura mensilmente in 12 mesi a partire dall’avvio operativo del primo programma specificato, e il restante 50% matura mensilmente in 12 mesi dopo l’avvio operativo del secondo programma specificato. A seguito della transazione la persona segnalante detiene beneficiariamente 8.048.555 azioni (la comunicazione indica che queste comprendono 55.193 azioni vincolate e 7.993.362 azioni di Classe A), mentre la segnalazione esclude alcune azioni di Classe B e opzioni.
Health In Tech, Inc. (HIT) - la persona informante, LinLin Qian, quien se desempeña como Directora Financiera, miembro del consejo y propietaria informada del 10%, recibió una concesión de 27.000 acciones restringidas de Clase A Common Stock el 15/08/2025. Las acciones restringidas se emitieron bajo el Health in Tech Equity Incentive Plan y se liberan al cumplirse hitos operativos: el 50% se adquiere mensualmente durante 12 meses tras el lanzamiento y operación del primer programa especificado, y el 50% restante se adquiere mensualmente durante 12 meses tras el lanzamiento y operación del segundo programa especificado. Tras la transacción, la persona informante posee de forma beneficiaria 8.048.555 acciones (el formulario indica que esto incluye 55.193 acciones restringidas y 7.993.362 acciones de Clase A), mientras que se excluyen ciertas acciones de Clase B y opciones.
Health In Tech, Inc. (HIT)의 신고자 LinLin Qian은 최고재무책임자(CFO), 이사이며 보고상 약 10%의 지분을 보유한 자로서 2025년 8월 15일에 27,000주의 Class A 제한주를 부여받았습니다. 해당 제한주는 Health in Tech Equity Incentive Plan에 따라 발행되었으며 운영적 마일스톤에 따라 권리가 취득됩니다: 지정된 첫 번째 프로그램이 가동되어 운영된 이후 12개월 동안 매월 50%가 취득되며, 두 번째 지정 프로그램이 가동되어 운영된 이후 남은 50%가 12개월 동안 매월 취득됩니다. 거래 이후 신고자는 8,048,555주를 실질적으로 보유하게 되며(보고서에 따르면 이에는 55,193주의 제한주와 7,993,362주의 Class A 주식이 포함됩니다), 일부 Class B 주식과 옵션은 보고서에서 제외되어 있습니다.
Health In Tech, Inc. (HIT) - la personne déclarante, LinLin Qian, qui occupe les postes de Chief Financial Officer, administratrice et détient environ 10% signalés, a reçu une attribution de 27 000 actions restreintes de Class A Common Stock le 15/08/2025. Les actions restreintes ont été émises dans le cadre du Health in Tech Equity Incentive Plan et sont soumises à des jalons opérationnels : 50% acquièrent droit mensuellement sur 12 mois après le lancement et la mise en service du premier programme spécifié, et les 50% restants acquièrent droit mensuellement sur 12 mois après le lancement et la mise en service du second programme spécifié. À la suite de la transaction, la personne déclarante détient de manière bénéficiaire 8 048 555 actions (la déclaration indique que cela inclut 55 193 actions restreintes et 7 993 362 actions de Classe A), certaines actions de Classe B et options étant exclues de la déclaration.
Health In Tech, Inc. (HIT) - die meldende Person LinLin Qian, die als Chief Financial Officer, Direktorin und mit rund 10% gemeldete Anteilseignerin fungiert, erhielt am 15.08.2025 eine Zuteilung von 27.000 eingeschränkten Aktien der Klasse A Common Stock. Die Restricted Shares wurden im Rahmen des Health in Tech Equity Incentive Plan ausgegeben und werden nach operativen Meilensteinen freigegeben: 50% werden monatlich über 12 Monate nach Inbetriebnahme des ersten genannten Programms zugeteilt, die verbleibenden 50% monatlich über 12 Monate nach Inbetriebnahme des zweiten genannten Programms. Nach der Transaktion besitzt die meldende Person wirtschaftlich 8.048.555 Aktien (laut Einreichung davon 55.193 Restricted Shares und 7.993.362 Class A-Aktien), während bestimmte Class B-Aktien und Optionen in der Einreichung ausgeschlossen sind.
FAQ
What did LinLin Qian report on Form 4 for HIT?
How do the restricted shares vest according to the Form 4?
How many shares does the reporting person beneficially own after the transaction?
Were any shares sold or purchased for cash in this transaction?
Does the Form 4 disclose other securities not included in the Class A total?
